Interaction of sanguinarine alkaloid, isolated from argemone oil, with hepatic cytochrome P450 in rats

Toxicology Mechanisms and Methods

Volumn 18, Issue 8, 2008, Pages 635-643

  Reddy, Naveen P ^a   Das, Mukul ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

Binding spectra; Cytochrome P450; Inhibition spectra and IC50; Relative binding efficiency; Sanguinarine

Indexed keywords

3 METHYLCHOLANTHRENE; ARGEMONE OIL; BENZOYLOXRESORUFIN DEETHYLASE; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 2B1; ETHOXYRESORUFIN DEETHYLASE; PENTOXYRESORUFIN DEETHYLASE; PHENOBARBITAL; SANGUINARINE; UNCLASSIFIED DRUG; UNCLASSIFIED ENZYME;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; IC 50; INCUBATION TIME; INHIBITION KINETICS; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ARGEMONE; RATTUS;

EID: 53149083404     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.1080/15376510701738439     Document Type: Article

References (45)

1. Ansari, K.M., Chauhan, L.K., Dhawan, A., Khanna, S.K., and Das, M. 2004. Unequivocal evidence of genotoxicity of argemone oil. Int. J. Cancer 112:890-895.
2. Ansari, K.M., Dhawan, A., Khanna, S.K., and Das, M. 2005. In vivo DNA damaging potential of sanguinarine alkaloid, isolated from argemone oil, using alkaline comet assay in mice. Food Chem. Toxicol. 43:147-153.
3. Babu, C.K., Khanna, S.K., and Das, M. 2006. Safety evaluation studies on argemone oil through dietary exposure for 90 days in rats. Food Chem. Toxicol. 44:1151-1157.
4. Babu, C.K., Khanna, S.K., and Das, M. 2007. Adulteration of mustard cooking oil with argemone oil: Indian food regulatory policies and antioxidant therapy both need revisitation. Antioxidant Redox Signal. 9:515-525.
5. Bartak, P., Simanek, V., Vlckova, M., Ulrichova, J., and Vespalec, R. 2003. Interaction of sanguinarine and chelerythrine with molecules containing mercapto group. J. Phys. Org. Chem. 16:803-810.
6. Bethizy, J.D., and Hayes, J.R. 1994. Metabolism, a determinant of toxicity. In Hayes, A.W. (Ed.), Principles and methods of toxicology 3rd ed., Raven Press, New York, pp. 59-100.
7. Burke, M.D., Thompson, S., Weaver, R.J., Wolf, C.R., and Mayer, R.T. 1994. Cytochrome P450 specificities of alkoxyresorufin-o-dealkylation in human and rat liver microsomes. Biochem. Pharmacol. 48:923-926.
8. Chiba, M., Jin, L., Neway, W., Vacca, J.P., Tata, J.R., Chapman, K., and Lin, J.H. 2001. P450 interaction with HIV protease inhibitors: Relationship between metabolic stability, inhibitory potency and P450 binding spectra. Drug. Metab. Disp. 29:1-3.
9. Cohen, H.G., Seifen, M., Straub, K.D., Tiferbeck, C., and Stermitz, E.R. 1978. Structural specificity of the Na-K ATPase inhibition by Sanguinarine, an isoquinoline benzophenanthridine alkaloid. Biochem. Pharmacol. 27:2555-2558.
10. Das, M., and Khanna, S.K. 1997. Clinicoepidemiological, toxicological and safety evaluation studies on argemone oil. Crit. Rev. Toxicol. 27:273-297.
11. Das, M., Ansari, K.M., Dhawan, A., Shukla, Y., and Khanna, S.K. 2005a. Correlation of DNA damage in dropsy patients to carcinogenic potential of argemone oil and isolated sanguinarine alkaloid in mice. Int. J. Cancer 117:709-717.
12. Das, M., Babu, K., Reddy, N.P., and Srivastava, L.M. 2005b. Oxidative damage of plasma proteins and lipids in Epidemic Dropsy patients: alterations in antioxidant status. Biochem. Biophys. Acta. Gen. 1722:209-217.
13. Das, M., Seth, P.K., and Mukhtar, H. 1981. Characterisation of microsomal aryl hydrocarbon hydroxylase in rat brain. J. Pharmacol. Exp. Therap. 216:156-161.
14. Das, M., Upreti, K.K., and Khanna, S.K. 1991. Biochemical toxicology of Argemone oil: role of reactive oxygen species in iron catalysed lipid peroxidation. Bull. Environ. Cotam. Toxicol. 46:422-430.
15. Davies, D.S., Gigen, P.L., and Gillette, J.R. 1969. Species and sex differences in electron transport systems in liver microsomes and their relationship to ethylmorphine demethylation. Life Sci. 8:85-91.
16. Dostal, J., and Potacek, M. 1990. Quaternary bezo(c) phenathridine alkaloids. Collec. Czec. Chem. Commn. 55:2840-2873.
17. Guengerich, F.P. 1995. Human cytochrome P450 enzymes. In Ortiz de Motellano, P.R. (Ed.), Cytochrome P450: Structure, Mechanism and Biochemistry, Plenum Press, New York, pp. 473-535.
18. Hrycay, E.G., and Bandiera, S.M. 2003. Spectral interactions of tetrachlorobiphenyls with hepatic microsomal Cytochrome P450 enzymes. Chem. Biol. Interac. 146:285-296.
19. Jordan, R.A. 1979. Cocaine induced hepatotoxicity. Thesis, University of Utah.
20. Karuzina, I.I., and Archakov, A.I. 1994. Hydrogen peroxide mediated inactivation of microsomal Cytochrome P450 during monoxygenase reactions. Free. Radic. Biol. Med. 17:557-567.
21. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. 1951. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:265-275.
22. Nebert, D.W., and Russel, D.W. 2002. Clinical importance of Cytochromes P450. Lancet 360:1155-1162.
23. Nerurkar, P.V., Prank, S.S., Thomas, P.E., Nims, R.W., and Lubet, R.A. 1993. Methoxyresorufin and Benzoyloxyresorufin: substrates preferentially metabolised by Cytochromes 1A2 and 2B respectively, in the rat and mouse. Biochem. Pharmacol. 46:933-943.
24. Omura, T., and Sato, R. 1964. Carbon monoxide binding pigment of rat liver microsomes. I. Evidence for its heme protein nature. J. Biol. Chem. 239:2370-2378.
25. Ortiz de Montellano, P.R., and Corriea, M.A. 1983. Suicidal destruction of Cytochrome P450 during oxidative drug metabolism. Annu. Rev. Pharmacol. Toxicol. 23:481-503.
26. Peeples, A., and Dalvi, R.R. 1982. Toxic alkaloids and their interaction with microsomal cytochrome P-450. J. Appl. Toxicol. 2:300-302.
27. Sarkar, S.N. 1948. Isolation from argemone oil of dihydrosanguinarine and sanguinarine. Toxicity of sanguinarine. J. Appl. Toxicol. 2:300-302.
28. Schenkman, J.B., and Sato, R. 1968. The relationship between the pH induced spectral change in ferri proto heme and the substrate induced spectral change of the hepatic mixed function oxidase. Mol. Pharmacol. 4:613-620.
29. Schenkman, J.B., Sligar, S.G., and Cinti, D.L. 1987. Substrate interaction with Cytochrome P450: In Schenkman, J.B., and Kupfer, R. (Eds.), Hepatic Cytochrome P450 monoxygenase system, vol. 108, International Encyclopaedia of Pharmacology and Therapeutics, Pergamon press, Oxford, pp 587-615.
30. Sen, A., and Maiti, M. 1994. Interaction of sanguinarine's iminium and alkanolamine form with calf thymus DNA. Biochem. Pharmacol. 48:2097-2102.
31. Stresser, D.M., Turner, S.D., Blanchard, A.P., Miller, V.P., and Crespi, C.L. 2002. Cytochrome P450 flourometric substrates: identification of isoform selective probes for rat CYP2D2 and human CYP3A4. Drug Metab. Disp. 30:845-852.
32. Tandon, S., Das, M., and Khanna, S.K. 1993. Biometabolic elimination and organ retention profile of argemone alkaloid, sanguinarine in rats and guinea pigs. Drug Metab. Disp. 21:194-197.
33. Tandon, S., Das, M., and Khanna, S.K. 1993a. Effect of sanguinarine on the transport of essential nutrients in an everted gut sac model: Role of Na+ K+ ATPase. Natural Toxins 1:235-240.
34. Ulrichova, J.,Walterova, D., Preininger, V., Slavik, J., Lenfeld, J., Cushman, M., and Simanek, V. 1983. Inhibition of acetylcholinesterase activity by some isoquinoline alkaloids. Planta Med. 48:111-115.
35. Upreti, K.K., Das, M., and Khanna, S.K. 1988. Biochemical toxicology of argemone alkaloids. Efects of lipid peroxidation in different subcellular fractions of liver. Toxicol. Lett. 42:301-308.
36. Upreti, K.K., Das, M., and Khanna, S.K. 1991a. Biochemical toxicology of Argemone oil: effect on hepatic cytochrome P-450 and xenobiotic metabolizing enzymes. J. Appl. Tox. 11:203-209.
37. Upreti, K.K., Das, M., and Khanna, S.K. 1991b. Role of antioxidants and scavengers of argemone oil induced toxicity in rats. Arch. Environ. Contam. Tox. 29:531-537.
38. Upreti, K.K., Das, M., Kumar, A., Singh, G.B., and Khanna, S.K. 1989. Biochemical toxicology of argemone oil IV: short-term oral feeding response in rats. Toxicology 58:285-298.
39. Vatsis, K.P., and Coon, M.J. 2001. Ipso-substitution by Cytochrome P450 with conversion of p-Hydroxybenzene derivatives to hydroquinone: evidence for hydro peroxide-iron as active oxygen species. Arch. Biochem. Biophys. 397:119-129.
40. Verma, S.K., Dev, G., Tyagi, A.K., Goomber, S., and Jain, G.V. 2001. Argemone mexicana poisoning: autopsy findings in two cases. For. Sci. Int. 115:135-141.
41. Vrba, J., Kosina, P., Ulrichova, J., and Modriansky, M. 2004. Involvement of Cytochrome P450 1A in sanguinarine detoxification. Toxicol. Lett. 151:375-387.
42. Walterova, D., Ulrichova, J., Preininger, V., Simanek, V., Lenfield, J., and Lasovsky, J. 1981. Inhibition of liver alanine amino transferase activity by some benzophenathridine alkaloids. J. Med. Chem. 24:100-1103.
43. Wang, Z.Y., Das, M., Bickers, D.R., and Mukhtar, H. 1988. Interaction of epicatechins derived from green tea with rat hepatic Cytochrome P450. Drug Metab. Disp. 16:98-103.
44. Williams, M.K., Dalvi, R., and Dalvi, R.R. 2000. Influence of 3-methylcholantherene pre-treatment on sanguinarine toxicity in mice. Vet. Hum. Toxicol. 42:196-198.
45. Zdarilova, A., Vrzal, R., Rypka, M., Ulrichova, J., and Dvorak, Z. 2006. Investigation of sanguinarine and chelerythrine effects on CYP1A1 expression and activity on human hepatoma cells. Food Chem. Toxicol. 44:242-249.